KROS Operating Cash Flow (Statement)
Keros Therapeutics Inc · Operating Cash Flow (Statement)
KROS Operating Cash Flow (Statement)
Latest reported-$47.99Mperiod ending
KROS TTM Cash from Operations (-$16.00M → -$47.99M)
TTM operating cash flow (statement)
High-resolution chart · PNG
KROS operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -47,993,000 | |
| -57,195,000 | |
| 107,505,000 | |
| 88,789,000 | |
| 55,040,000 | |
| 44,862,000 | |
| -160,869,000 | |
| -140,320,000 | |
| -143,802,000 | |
| -134,833,000 | |
| -124,508,000 | |
| -120,492,000 | |
| -111,112,000 | |
| -102,870,000 | |
| -70,062,000 | |
| -68,184,000 | |
| -58,023,000 | |
| -53,070,000 | |
| -62,148,000 | |
| -50,574,000 | |
| -46,989,000 | |
| -39,279,000 | |
| -36,894,000 | |
| -34,401,000 | |
| -26,500,000 | |
| -21,605,000 | |
| -15,998,000 |